Free tool
FAERS Monitor: Morphine Sulfate
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 202515 or its brand name (Morphine Sulfate, Morphine Sulfate). Reports on generic versions are filed under their own applications.
Reports
67,702
Serious
52,278
77% of reports
Hospitalization
16,613
Death reported
12,172
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug dependence10,516
- drug hypersensitivity10,154
- pain9,236
- overdose7,799
- emotional distress5,177
- nausea4,695
- dependence4,682
- drug ineffective4,473
- death4,265
- fatigue3,372
- drug withdrawal syndrome3,367
- vomiting3,311
- headache3,058
- off label use3,036
- toxicity to various agents2,564
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,243 |
| 2005 | 1,049 |
| 2006 | 952 |
| 2007 | 529 |
| 2008 | 649 |
| 2009 | 698 |
| 2010 | 892 |
| 2011 | 1,190 |
| 2012 | 1,838 |
| 2013 | 1,464 |
| 2014 | 1,860 |
| 2015 | 2,350 |
| 2016 | 2,902 |
| 2017 | 2,703 |
| 2018 | 5,576 |
| 2019 | 4,345 |
| 2020 | 3,840 |
| 2021 | 7,871 |
| 2022 | 8,454 |
| 2023 | 8,186 |
| 2024 | 3,559 |
| 2025 | 3,350 |
| 2026 | 2,199 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,986,457 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| dependenceSignal | 4,682 | 28.9 | 28.1 | 115,691 |
| drug dependenceSignal | 10,516 | 21.7 | 21.3 | 195,249 |
| drug hypersensitivitySignal | 10,154 | 17.1 | 16.8 | 147,646 |
| emotional distressSignal | 5,177 | 13.8 | 13.5 | 59,330 |
| drug withdrawal syndromeSignal | 3,367 | 12.4 | 11.9 | 33,926 |
| overdoseSignal | 7,799 | 11.6 | 11.4 | 73,676 |
| toxicity to various agentsSignal | 2,564 | 4.8 | 4.6 | 7,607 |
| painSignal | 9,236 | 4.7 | 4.6 | 27,534 |
| vomitingSignal | 3,311 | 2.2 | 2.1 | 2,190 |
| nausea | 4,695 | 1.8 | 1.8 | 1,886 |
| death | 4,265 | 1.5 | 1.5 | 839 |
| headache | 3,058 | 1.5 | 1.5 | 554 |
| fatigue | 3,372 | 1.3 | 1.3 | 311 |
| off label use | 3,036 | 1.1 | 1.0 | 17 |
| drug ineffective | 4,473 | 1.1 | 1.0 | 13 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.